Vol.
184,
No.
April
30,
1992
BIOCHEMICAL
2, 1992
AND
BIOPHYSICAL
COMMUNICATIONS
RESEARCH
Pages
893-899
CYCLIC AMP-DEPENDENT PHOSPHORYLATION OF THE INOSITOL-1,4,5-TRISPHOSPHATE RECEPTOR INHIBITS Ca2+ RELEASE FROM PLATELET MEMBRANES Todd
M. Quinton
University
Received
March
12,
and William
of Louisville, Louisville,
L.
School KY 40292
Dean
of Medicine
1992
SUMMARY: Purified internal platelet membranes were treated with the catalytic of protein kinase A to determine its effect on inositol-1,4,5subunit Release kinetics were monitored using trisphosphate (IP3)-mediated Ca2+ release. rhod-2, a Ca2+-specific fluorophore. Protein kinase A maximally inhibit-d the rate of IP,-mediated Cazf release by approximately 30% at saturating IP, (10 PM). This inhibition was eliminated by pretreatment with a specific kinase inhibitor peptide. Partial purification of the platelet IP3 receptor showed that both Since endogenous kinases and added Akinase directly phosphorylate the receptor. the IP3 receptor is phosphorylated in the absence of added kinase, the observed inhibition (30%) by protein kinase A does not represent the maximal effect of phosphorylation. 4' 1992 Academic Press, Inc.
Ca2+ is an important many
metabolic
activation and
system low
(2).
located
Ca2+ and
due to reduced
phosphorylation
the
dense
dense
CaZt is sequestered process
both
Tohmatsu
addition,
tubular
permeabilized
platelets
IPs-sensitive
stores,
al. caused
although
of CAMP-dependentphosphorylation available platelet
Ca2+ both dense
Abbreviations: effect; IP3,
by stimulating
tubular
inositol
membranes reported
that et al.
of
dense
tubular
in maintaining activation
shown
that
CAMP-dependent
increases
the
and in intact
in the amount failed
effect at
which
platelets
(8),
by CAMP.
CAMP to this
CAMP may Ca2+ release
In
saponin-
of Ca2+ released to observe
Thus,
and inhibiting
rate
function of
this
is
of
in isolatedmembranes. Ca2+ uptake
component
part
addition (10)
the
involved
of platelet
a 50% decrease O'Rourke
(6,7)
of
least
has been
membranes
and
regulation
Ca2+-ATPases
Platelet
and at
to inhibition (9)
is
activation. It
system
in isolated
et
membrane
CAMP (3),
Ca2+ (4,5).
integral
is regulatedby
system
Ca2' for
contribute
may
plasma
tubular
increase
cytoplasmic df
the
in the
an
Ca2+ concentration in
that
involved
Ca2+ is
platelets,
in providing
by agonists
messenger
both
Consequently,
resting
and this
In
The intracellular
channels
inhibited is
processes.
(1).
Ca2'
intracellular
from effect
decrease in the
system.
EC,, > concentration 1,4,5-trisphosphate.
required
to
elicit
50% of
the
maximum
Vol.
184,
No.
2,
1992
The effect appears
to
increase
in the
be
phosphorylation
This system
has to IP,)
and liver
for
in brain the
opposite
as that
may be a consequence
paper
examines
membranes
the
on the
of
effect rate
IP,
effect
observed of
et
microsomes,
EC,, for
MATERIALS
COMMUNICATIONS
These forms release
of
in
of of
IP, platelet
a lo-fold
CAMP-dependent
Thus,
differences the
Ca2+ release
reported
in liver,
(12).
phosphorylation
of IP,-mediated
(11)
Ca2+ release
in brain. multiple
al. while
5-fold on
RESEARCH
on IPa-mediated
Supattapone
IP,
the
BIOPHYSICAL
phosphorylation
tissue-specific. EC,,
AND
CAMP-dependent
decreased
phosphorylation sensitivity
of
BIOCHEMICAL
CAMP-dependent liver
(increased between
receptor dense
brain
(13-15). tubular
Ca2+.
AND METHODS
Materials. Outdated human platelets were obtained from the Louisville chapter of the American Red Cross. Rhod-2 was purchased from Molecular Probes, Inc. The catalytic subunit of CAMP-dependent protein kinase (protein kinase A) heparinagarose and protein kinase inhibitor peptide of Cheng et a1.(16) were purchased from Sigma Chemical Co. Thapsigargin and inositol 1,4,5-trisphosphate were Wheat germ agglutinin-agarose was a product of purchased from LC Services, Inc. Pharmacia. [T-~~P]ATP was purchased from Amersham and [3H]IP3 was from New England Nuclear. Platelet internal membranes were purified according to Dean (17). Ca2+ Methods. release rates were determined from the rate of change in fluorescence of rhod-2. Fluorescence was monitored with an SIM-Aminco SPF-500C spectrofluorometer using an excitation wavelength of 553 nm and an emission wavelength of 576 nm. A typical assay mixture consisted of 2.5 pM Ca2+, 10 mM Tes buffer at pH 7.5, 100 5 PM rhod-2, and 0.2 mg platelet internal mM KCl, 50 mM K,HPO,, 10% glycerol, titration of rhod-2 was carried membrane protein in 2 mL at 37O C. A complete out under the above assay conditions (with 5 mM MgATP added) to determine the linear range of Ca2+ response and the relationship between Ca2+ concentration and emission magnitude. MgATP was added to a concentration of 5 mM to initiate uptake of Ca2+ into membrane vesicles. The amount of Ca z+ loaded into the vesicles was normalized for each assay by allowing a decrease of 2.0 fluorescence units (corresponding to about 10 nmol Ca2+) during uptake. Thapsigargin (200 nM) (23) was added to inhibit uptake. IPs was then added to a concentration of 10 PM to initiate Ca2+ release from vesicles (19). CAMP-dependent protein kinase was incubated at 30' C for 10 minutes in the absence or presence of protein kinase inhibitor, and was added after the addition of ATP and membranes. Rates of Ca2+ release were determined from first order plots of the fluorescence data (20) using the expression:
ln[ l- (Fobs - F,dFmax - F,d 1 where Fobs is the observed fluorescence at a time after IP3 addition, Fmin is the fluorescence at the point of IP, addition, and F,,, is the maximum level of fluorescence after IP3 addition. Zero time was at the point of IP, addition. Rates were obtained by multiplying the rate constant derived from the first order Since protein kinase A did not plot by the total amount of Ca2+ released by IP,. affect the extent of release, the same value of total Ca2+ was used for completed on the same day with the same calculating rates for experiments membrane preparation. The platelet IP3 receptor was partially purified after solubilizationwith Triton X-100 as described by Mourney et al. (21). Purified platelet membranes (5 mg/mL) were solubilized with 1.5% (w/v) Triton X-100 at pH 7.7 in 50 mM Tris containing 0.15 M NaCl, 1 mM EDTA and with PMSF (40 PM), leupeptin (10 pg/mL), pepstatin A (10 pg/mL) and aprotinin (20 pg/mL) added to inhibit proteolysis. After centrifugation at 100,000 x G, the supernatant was applied to a heparinagarose column equilibrated with solubilizationbuffer containing 0.1% TritonX100 and 0.25 M NaCl. The IP3 receptor was eluted with a 0.5 - 1.0 M NaCl gradient and was then applied to a wheat germ agglutinin-agarose column (15) 894
Vol.
184, No. 2, 1992
BIOCHEMICAL
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
equilibrated with solubilization buffer containing 0.1% Triton X-100 and 0.6 M NaCl. The IP3 receptor was eluted with 0.2 M N-acetylglucosamine. IP3 binding measurements with 5 nM [3H]IP3 (21) indicated approximately loo-fold purification of the receptor to a level of 15 pmol IP3 bound/mg protein. SDS polyacrylamide gel electrophoresis was carried out according to Laemmli (22) on 5% acrylamide gels. Phosphorylation of platelet membranes was accomplished as described by Adunyah and Dean (7). Platelet membranes (75 pg) were treated with 2.5 pg of catalytic subunit of CAMP-dependent protein kinase in the presence of 10 mM Tes buffer, 0.1 M KCl, 0.05 M NaPO,, 1 mM MgATP and 20 $i of [f-32P]ATP. After incubation for 5 min at 30" C, the reaction was stopped by chilling to 0" C and membranes were removed by centrifugation at 100,000 x G. In control experiments protein kinase A was omitted, Phosphorylated membranes were solubilized with Laemmli sample dilution buffer (22), electrophoresed on 5% polyacrylamide gels, and phosphorylation was visualized by autoradiography.
RESULTS In
order
simultaneous addition to
to re-uptake
of
inhibit
of
Ca2+,
has been
all
forms
of
endoplasmic
membrane
Ca2+-pumps
transport
assays
thapsigargin.
in The
that
our
the total
shown
presence
that
membrane rates
were
release
activity
rates was
reticulum-type (Fig.
1) of
and
absence
Ca2+ uptake
preparation determined
is from
by devoid semilog
1.
Effects
by
prior
to
is
sufficient while
2 show (Fig. 200 of
not
typical 2)
of
Ca2+ 200
100
200
300
400
of thapsigargin.
500
600
700
plasma
plots
800
(see
membrane inset
900
(WC)
IP,, and catalytic
subunit of protein kinase A on Ca2+ uptake and release. Ca'+ uptake was measured using rhod-2 as described in "Materials and Methods". Thapsigargin (tg, 200 nM), IP, (10 PM) and protein kinase A (PKA, 100 units) were added at the times indicated by the arrows. The lower trace was offset by two fluorescence units to enable comparison of the two traces. Both traces are from the same membrane preparation at the identical protein concentration (0.2 mg/mL). The inset shows semilog plots of fluorescence data after the addition of IP, used to determine first order rate constants.
895
I-M
nM thapsigargin
2.6 nmollmin
Time
Figure
(23)
1 and
damped
inhibited
Ca'+-ATPases,
Figures
I 0
not
200 nM thapsigargin
(18).
inhibition
purified
Ca2+ release
Ca2+
Ca'+-ATPase
It
plasma
Ca'+-ATPase.
IP,-mediated
IP,.
affecting
indicates
obtain
in
Vol.
184,
No.
2,
1992
BIOCHEMICAL
AND
BIOPHYSICAL
RESEARCH
500
700
COMMUNICATIONS
6-
0
200
100
300
400 Time
600
800
900
(set)
Figure 2. Effect of protein kinase A on IP,-mediated CaZt release and r-e-uptake. Experimental detail is the same as in Fig. 1 except thapsigargin was not added to inhibit Ca'+ uptake and the data were obtained from a different membrane preparation. Arrows indicate the extent and duration of the IP3-induced CaZ+ release from the time of addition of IP,. The Ca2+ uptake rates obtained from the indicated lines are 0.5 nmol/min in the absence of PKA and 0.6 nmol/min after addition of IP3.
Fig.
1) as described
IPs-mediated kinase
Ca2+ release
addition
(Fig.
inset),
was not
extent
of
kinase (vertical return
arrow) to the
was reduced
the
experiment
was inhibited Table
was inhibited membrane
when
peptide
inhibited
arrows.
The
at I shows
that
(16)
prior
was to
the
first
I at In order
loo-fold
(see
was not
10 PM IP, to identify Methods)
significantly
(data
not
time
rate
of
mixture rate
to
arrow) for This
of
four effect
kinase
(Table of
the
Ca"
required
a protein
100 units from
by the
inhibition
of
different
of
in one membrane
assay the
and
(horizontal
with
of
rate
A
I).
To
kinase
was
Ca2+ release
results
at
presented
shown).
the platelet
and the
and the addition
Ca'+-
extent
release
incubated
ensure that 10 PM IPs was saturating, determined at 20 and 50 PM IP,. The inhibition concentrations
maximum
was 26 + 10%.
the
in Table
the
of re-uptake
The average
effect
efflux
in
of kinase to
the
both
both
Ca'+ release
16%.
addition
the
of IP,
by 100 units
kinase
2,
addition
the point
by a maximum of the
Fig.
with
When the
reduction
is due to stimulation in
1 and 2,
IP,-mediated
of Ca2+ released.
addition
the
in Figs.
that
was inhibited
of
by
50% by kinase
preparations
rate
kinase
shown
Ca2+ concentration
eliminated
inhibitor
2),
demonstrated
As shown the
amount
(20)
Ca'+-ATPase
A reduced
total
indicated
et al.
process. When the
of thapsigargin
by 40%.
preparation different was
absence In
the
(Fig. as
Meyer
order
kinase
affecting
inhibited
(6,7).
a first
protein
CaZ+ efflux
in the
section.
Ca2+ release.
l),
without
ATPase release
is
inhibited
thapsigargin (see
in the Methods
IP3 receptor,
partially
purified 896
the receptor receptor
is
shown
was purified in Fig.
3.
Vol.
184,
No.
2,
1992
BIOCHEMICAL
Table protein
and
kinase (units)
Effect kinase
I.
added
lane
high
Ca2+ release" (nmol/min) 3.1 +/0.1 2.6 +/0.1 2.6 +/0.1 3.1 +/0.1 3.1 +/0.2 __ - _ _ _ _ _ _ inhibitor.
receptor l),
but
by
added
is
close
a minor
protein
protein
is of
in our kinase
reported
membrane (Student's
the
purified
weight
membrane
by both
IP3
preparations. t-test).
of
by Mourney
et
4).
250 kDa (Fig.
al.
This
result
is
3,
The IP3
(Fig.
kinases
3,
(lane
suggests
on Ca2+ release
receptor
(21).
preparation
endogenous
phosphorylation
because
kinase Ca2+ release
(n-3).
4 different at P